Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions

NCT03070236 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT03070236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03070236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 1, 2017
Completion date
February 25, 2030
Enrollment
912 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer